Trial design and setting
Câncer
FEMALE BREAST CANCER, DISEASE
BREAST-MRI is a phase III, randomized, open-label, single-center trial including female breast cancer participants with stage 0-III disease and eligible for breast-conserving surgery at Instituto do Câncer do Estado de São Paulo (ICESP, Brazil) from November 2014 to July 2020.